Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-02-26 to 2025-03-19
Current total value of award: $31576.62
Description: 4567410380!TYSABRI 300 MG/15 ML VIAL 15ML